Zotefoams (ZTF)

Sector:

Industrial Chemicals

Index:

FTSE Small Cap

445.00p
   
  • Change Today:
    -5.00p
  • 52 Week High: 500.00
  • 52 Week Low: 353.00
  • Currency: UK Pounds
  • Shares Issued: 48.62m
  • Volume: 1,089
  • Market Cap: £216.36m
  • RiskGrade: 186

Zotefoams revenue reaches record high after capacity investments

By Josh White

Date: Tuesday 13 Mar 2018

LONDON (ShareCast) - (ShareCast News) - Cellular material technology company Zotefoams announced its unaudited preliminary results for the 12 months ended 31 December on Tuesday, reporting a 22% increase in group revenue to a record £70.15m.
The London-listed firm said of that, it saw 18% growth in its 'AZOTE' foams, with strong market mix improvements, along with increases of 32% in high-performance products and 56% in 'MuCell' extrusion.

It claimed a 17% increase in group revenue in constant currency.

Reported profit before tax and exceptional items rose 22% to a record £8.81m, with the group also posting an 8% increase in reported profit before tax to £7.55m.

On the strategic front, Zotefoams completed its major US capacity expansion investment during the year, which the board said was now producing high-quality foam.

It also entered into a strategic partnership with Nike, augmenting its growth prospects in high-performance products, and made "significant" investments to deliver capacity for expected future growth.

Those included the start of a £12m low-pressure capacity investment in the UK, as well as the approval of a further investment of $9m to double its high-pressure autoclave capacity in Kentucky.

"In 2017 Zotefoams delivered significant financial and strategic progress," said Zotefoams group CEO David Stirling.

"Sales and profits grew strongly to record levels and key investments to support future growth progressed well."

Stirling said the current year had also started positively, with first quarter order volumes 8% higher than 2017 and an increased proportion of higher-value high-performance products sales.

"Our investment in capacity in Kentucky has now been commissioned and we made the first sales in February 2018.

"We have also broken ground on our investment in Croydon, which increases low-pressure capacity for our high-performance products businesses by a factor of six," Stirling explained.

"The board has now approved the commissioning of our second high-pressure autoclave in the USA, with a view to having this operational in late 2019."

Stirling added that the board believed investment in product and market development over previous years, together with investment in capacity to meet expected future levels of demand, left the company well placed to support future growth.

"While being mindful of the risks posed by the macroeconomic environment and a strengthening in the value of sterling, the board remains confident about the future prospects for our business."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Zotefoams Market Data

Currency UK Pounds
Share Price 445.00p
Change Today -5.00p
% Change -1.11 %
52 Week High 500.00
52 Week Low 353.00
Volume 1,089
Shares Issued 48.62m
Market Cap £216.36m
RiskGrade 186

Zotefoams Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.5% below the market average32.5% below the market average32.5% below the market average32.5% below the market average32.5% below the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Price Trend
20.27% below the market average20.27% below the market average20.27% below the market average20.27% below the market average20.27% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
Income
65.67% below the market average65.67% below the market average65.67% below the market average65.67% below the market average65.67% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
5.56% above the market average5.56% above the market average5.56% above the market average5.56% above the market average5.56% above the market average
44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Zotefoams Dividends

  Latest Previous
  Final Interim
Ex-Div 06-May-21 10-Sep-20
Paid 01-Jun-21 09-Oct-20
Amount 4.27p 2.03p

Trades for 27-Jul-2021

Time Volume / Share Price
14:14 269 @ 445.00p
13:38 500 @ 444.00p
12:02 160 @ 437.00p
11:30 160 @ 439.00p

Zotefoams Key Personnel

CEO David Stirling
Finance Director Gary McGrath

Top of Page